TG Therapeutics, Inc.
TGTX
$30.63
-$1.04-3.28%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 390.90M | 28.19M | 5.06M | 23.33M | 3.88M |
| Total Depreciation and Amortization | 17.00K | 13.00K | 8.00K | 9.00K | 11.00K |
| Total Amortization of Deferred Charges | 349.00K | 350.00K | 352.00K | 356.00K | 467.00K |
| Total Other Non-Cash Items | -349.70M | 15.63M | 14.41M | 11.40M | 15.26M |
| Change in Net Operating Assets | -64.71M | -36.74M | -48.54M | -60.74M | -31.83M |
| Cash from Operations | -23.15M | 7.44M | -28.72M | -25.64M | -12.21M |
| Capital Expenditure | -80.00K | -42.00K | -25.00K | -21.00K | -24.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 46.44M | -3.95M | -12.91M | 15.81M | -9.31M |
| Cash from Investing | 46.36M | -3.99M | -12.93M | 15.79M | -9.33M |
| Total Debt Issued | -- | -- | -- | 0.00 | 244.82M |
| Total Debt Repaid | -- | -- | -- | 0.00 | -107.55M |
| Issuance of Common Stock | 0.00 | 432.00K | 21.00K | 570.00K | 199.00K |
| Repurchase of Common Stock | -78.24M | -6.88M | -6.12M | -6.61M | -2.15M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -31.00K | -858.00K |
| Cash from Financing | -78.24M | -6.44M | -6.10M | -6.07M | 134.45M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -55.03M | -3.00M | -47.75M | -15.93M | 112.92M |